Navigation Links
Studies Presented at Diabetes Technology Meeting Demonstrate the Accuracy of ARKRAY Blood Glucose Meters and Test Strips
Date:10/23/2015

MINNEAPOLIS, Oct. 23, 2015 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes care products, announced that two studies presented yesterday at the Diabetes Technology Meeting in Bethesda, Maryland  demonstrated the accuracy of ARKRAY's GLUCOCARD® Shine meter and the GLUCOCARD Vital™ meter in measuring blood glucose levels. The ability to accurately measure glucose levels in blood is essential for people afflicted with diabetes so they can effectively manage the disease, according to the American Diabetes Association (ADA).

"The results of these studies show ARKRAY products meet new ISO accuracy performance requirements for blood glucose meters," said ARKRAY USA President Jonathan Chapman. "These studies demonstrate our commitment to provide affordable, accurate blood glucose meters and test strips that help those afflicted with diabetes to live a more fulfilling and healthier life."

Diabetes, or diabetes mellitus, is a metabolic type of disease in which affected people have high blood glucose (blood sugar), either because insulin production is inadequate (Type 2), or because the islet cells in the pancreas no longer produce insulin (Type 1, sometimes referred to juvenile diabetes). People with untreated diabetes typically experience frequent urination, become increasingly thirsty and hungry. The ADA estimates that more than 30 million Americans suffer from either Type 1 or Type 2 diabetes and that 25.9% of American's 65 years of age or greater will have diabetes.

About ARKRAY USA, Inc.

ARKRAY USA, Inc. is a division of ARKRAY, a global leader in diabetes care with headquarters in Kyoto, Japan. For more than half a century, ARKRAY has pioneered products to ensure that people who have diabetes - and the health professionals who care for them - can better manage the condition.  ARKRAY currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the U.S. The Company has a long history of developing cutting edge technology such as the first portable glucose analyzer available in the United States; the first HbA1C analyzer; and the first hand-held blood glucose meter. For more information, visit www.arkrayusa.com.

 


'/>"/>
SOURCE ARKRAY USA, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Studies Show Respiratory Volume Monitoring May Offer Better Protection for Women in Labor and Obese Patients
2. Isis Pharmaceuticals Initiates SHINE Study to Provide ISIS-SMN Rx for Patients With SMA Who Have Completed the Phase 3 ENDEAR and CHERISH Studies
3. MEI Pharma Announces Data from Phase II Clinical Studies of Pracinostat Accepted for Oral Presentation at American Society of Hematology Annual Meeting
4. Xybion announces that Novo Nordisk selects Pristima to manage pharmacology research studies across all research sites
5. UbiVac Announces Collaboration with Johnson & Johnson Innovation to Develop and Test, in Preclinical Studies, a Vaccine to Intercept Oral Cancer
6. AbbVies ABT-494 Meets Primary Endpoint in Two Phase 2 Studies in Rheumatoid Arthritis
7. DelMar Pharmaceuticals Presents Clinical Protocol for Advancement of VAL-083 into Phase IV Studies as a Treatment for Non-Small Cell Lung Cancer
8. Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015
9. NeuroPhages NPT088 Universally Targets Misfolded Proteins in Preclinical Studies Highlighted in Oral Session at the Alzheimers Association International Conference
10. Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood Cancer
11. New Clinical Studies Prove that Asking Patients the Right Questions Can Improve Quality, Reduce Costs of Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2019)... (PRWEB) , ... December 05, ... ... announce its entrance into the Amazon Web Services (AWS) Public Sector Partner ... , The Public Sector Partner program recognizes and collaborates with partners that ...
(Date:12/4/2019)... ... December 04, 2019 , ... Tenex Health, Inc., ... technologies to treat chronic pain in soft and hard tissue, recently achieved a ... , Dr. Bernard Morrey, Chief Medical Officer of Tenex Health, said, ...
(Date:12/2/2019)... ... December 02, 2019 , ... Data integration has been a pharma industry buzzword ... and external data sources, staff are still working in silos and are not aware ... take six weeks or more, and nearly one-third of qualified investigators may be overlooked. ...
Breaking Medicine Technology:
(Date:12/5/2019)... ... December 05, 2019 , ... Abide, the #1 Christian meditation and ... this year using Bible-based bedtime stories. Listeners have recovered from bad dreams and night ... Center for Disease Control, one third of Americans suffer from poor sleep, which is ...
(Date:12/5/2019)... ... December 05, 2019 , ... Today at M Health Fairview University ... staff member who will to help them take medicine, relax during anxious moments, ... , Rocket, presented by NutriSource® is a golden retriever and the first and ...
(Date:12/4/2019)... ... December 04, 2019 , ... Healthcare Real Estate ... only national awards dedicated to recognizing excellence in the areas of healthcare real ... in nine different categories during the GlobeSt Healthcare Conference today in Scottsdale, Ariz. ...
(Date:12/2/2019)... , ... December 02, 2019 , ... More than $400 ... midnight on December 31. While many people spend their tax-free funds throughout the year, ... on New Year’s Eve. In an effort to help account holders use -- not ...
(Date:11/30/2019)... ... 28, 2019 , ... As American families gather to celebrate Thanksgiving this year, ... of their loved ones. For those with a life-limiting illness, hospice care can provide ... , Spending their final months at home takes on special meaning this time of ...
Breaking Medicine News(10 mins):